TrialInternational journal of hematology2012

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.

Katsuto Takenaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.